Literature DB >> 33573743

Absolute Coronary Blood Flow Measured by Continuous Thermodilution in Patients With Ischemia and Nonobstructive Disease.

Regina E Konst1, Suzette E Elias-Smale1, Dario Pellegrini2, Mariëlle Hartzema-Meijer1, Bas J C van Uden1, Tijn P J Jansen1, Priya Vart3, Helmut Gehlmann1, Angela H E M Maas1, Niels van Royen1, Peter Damman4.   

Abstract

BACKGROUND: Intracoronary continuous thermodilution is a novel technique to quantify absolute coronary flow (Q) and resistance (R) and has potential advantages over current methods such as coronary flow reserve (CFR) and index of microvascular resistance (IMR). However, no data are available in patients with ischemia and nonobstructive coronary artery disease (INOCA).
OBJECTIVES: This study aimed to assess the relationship of Q and R with the established CFR/IMR in INOCA patients, to explore the potential of absolute Q, and to predict self-reported angina.
METHODS: Consecutive INOCA patients (n = 84; 87% women; mean age 56 ± 8 years) underwent coronary function testing, including acetylcholine (ACH) provocation testing, adenosine (ADE) testing (CFR/IMR), and continuous thermodilution (absolute Q and R) with saline-induced hyperemia.
RESULTS: ACH testing was abnormal (ACH+) in 87%, and ADE testing (ADE+) in 38%. The median absolute Q was 198 ml/min, and the median absolute R was 416 WU. The absolute R was higher in patients with ADE+ versus ADE- (495 WU vs. 375 WU; p = 0.04) but did not differ between patients with ACH+ versus ACH- (421 WU vs. 409 WU; p = 0.74). Low Q and high R were associated with severe angina (odds ratio: 3.09; 95% confidence interval: 1.16 to 8.28; p = 0.03; and odds ratio: 2.60; 95% confidence interval: 0.99 to 6.81; p = 0.05), respectively.
CONCLUSIONS: In this study, absolute R was higher in patients with abnormal CFR/IMR, whereas both Q and R were unrelated to coronary vasospasm. Q and R were associated with angina, although their exact predictive value should be determined in larger studies.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  INOCA; absolute coronary blood flow; acetylcholine; adenosine; coronary function test; coronary physiology

Year:  2021        PMID: 33573743     DOI: 10.1016/j.jacc.2020.12.019

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Angina with coronary microvascular dysfunction and its physiological assessment: a review with cases.

Authors:  Pitt O Lim
Journal:  Br J Cardiol       Date:  2022-04-20

Review 2.  Methods to evaluate vascular function: a crucial approach towards predictive, preventive, and personalised medicine.

Authors:  Cristina M Sena; Lino Gonçalves; Raquel Seiça
Journal:  EPMA J       Date:  2022-05-20       Impact factor: 8.836

Review 3.  Invasive Assessment of Coronary Microvascular Function.

Authors:  Fabio Mangiacapra; Michele Mattia Viscusi; Giuseppe Verolino; Luca Paolucci; Annunziata Nusca; Rosetta Melfi; Gian Paolo Ussia; Francesco Grigioni
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

4.  Relation Between Coronary Tortuosity and Vasomotor Dysfunction in Patients Without Obstructed Coronaries?

Authors:  Tijn P J Jansen; Kyra van Keeken; Regina E Konst; Aukelien Dimitriu-Leen; Angela H E M Maas; Niels van Royen; Peter Damman; Suzette Elias-Smale
Journal:  Front Cardiovasc Med       Date:  2022-01-13

Review 5.  Pathophysiologic Basis and Diagnostic Approaches for Ischemia With Non-obstructive Coronary Arteries: A Literature Review.

Authors:  Bingqi Fu; Xuebiao Wei; Yingwen Lin; Jiyan Chen; Danqing Yu
Journal:  Front Cardiovasc Med       Date:  2022-03-17

Review 6.  Coronary functional assessment in non-obstructive coronary artery disease: Present situation and future direction.

Authors:  Changlin Zhai; Hongyan Fan; Yujuan Zhu; Yunqing Chen; Liang Shen
Journal:  Front Cardiovasc Med       Date:  2022-08-23

Review 7.  Invasive evaluation of coronary microvascular dysfunction.

Authors:  Alejandro Travieso; Adrian Jeronimo-Baza; Daniel Faria; Asad Shabbir; Hernan Mejia-Rentería; Javier Escaned
Journal:  J Nucl Cardiol       Date:  2022-05-26       Impact factor: 3.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.